Overview

Ologen Collagen Matrix Safety and Effective Comparison With Mitomycin-C(MMC) in Glaucoma Surgery

Status:
Completed
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
To compare the safety and effectiveness of oculusgen (ologen) collagen matrix implantation and Mitomycin-C(MMC) in glaucoma surgery.
Phase:
Phase 4
Details
Lead Sponsor:
Pro Top & Mediking Company Limited
Treatments:
Mitomycin
Mitomycins